FISH NSCLC ALK1 ROS1 Genetic Test: Your Path to Personalised Lung Cancer Treatment
Receiving a non-small cell lung cancer diagnosis can feel overwhelming, but understanding your cancer’s specific genetic makeup provides hope and direction. The FISH NSCLC ALK1 ROS1 Test offers crucial insights that could transform your treatment journey, helping identify whether targeted therapies might be your most effective option.
Understanding Your FISH NSCLC ALK1 ROS1 Test
This specialised genetic test uses Fluorescence In Situ Hybridisation (FISH) technology to detect specific gene rearrangements in your lung cancer cells. Unlike standard pathology tests, FISH testing provides molecular-level precision, identifying whether your cancer has ALK1 or ROS1 gene changes that respond exceptionally well to targeted medications.
Think of it as getting the exact blueprint of your cancer – information that helps your oncologist choose treatments specifically designed for your unique cancer profile rather than using a one-size-fits-all approach.
Who Should Consider This Test?
This test is particularly important if you:
- Have been diagnosed with non-small cell lung cancer (NSCLC)
- Are exploring targeted therapy options beyond standard chemotherapy
- Want to understand if your cancer might respond to ALK or ROS1 inhibitors
- Have adenocarcinoma subtype of lung cancer
- Are a non-smoker or light smoker with lung cancer
- Want to maximise your treatment effectiveness while minimising side effects
Many patients find that knowing their genetic status provides not just treatment direction but also emotional relief – understanding exactly what they’re dealing with reduces uncertainty and empowers informed decisions.
Why This Test Matters for Your Health Journey
The FISH NSCLC ALK1 ROS1 Test offers several life-changing benefits:
- Personalised Treatment Planning: Identifies whether targeted therapies could be more effective than traditional chemotherapy
- Reduced Treatment Side Effects: Targeted therapies often have fewer side effects than conventional chemotherapy
- Improved Response Rates: Patients with ALK or ROS1 rearrangements often respond exceptionally well to specific targeted medications
- Peace of Mind: Knowing your cancer’s genetic profile reduces uncertainty and helps you feel more in control
- Time-Sensitive Insights: With results in just 4 working days, you can make timely treatment decisions
Understanding Your Test Results
Your results will clearly indicate whether ALK1 or ROS1 gene rearrangements are present in your cancer cells. A positive result means you’re likely to benefit from targeted therapies specifically designed for these genetic changes. A negative result provides valuable information that helps your oncologist explore other effective treatment options.
Our detailed report includes easy-to-understand explanations and your oncologist will help you interpret what these findings mean for your specific treatment plan. Remember – every piece of information brings you closer to the most effective treatment strategy for your unique situation.
Transparent Pricing – Exceptional Value
| Service | Regular Price | Special Price | Savings |
|---|---|---|---|
| FISH NSCLC ALK1 ROS1 Genetic Test | ZAR 5,350 | ZAR 2,000 |
This investment in precise genetic testing could save you from unnecessary treatments and help identify the most effective therapy for your specific cancer type.
Why Trust Oracle Genomics?
At Oracle Genomics, we understand that cancer testing requires not just technical excellence but also compassion and understanding. Our commitment to you includes:
- Nationwide Coverage: Accessible testing across Johannesburg, Cape Town, Durban, Pretoria and throughout South Africa
- Medical Expertise: Specialised testing reviewed by experienced molecular pathologists
- Rapid Turnaround: Sample processing daily by 4 PM, with results in just 4 working days
- Accuracy Guarantee: Advanced FISH technology ensuring reliable, precise results
- Patient-Centred Approach: We prioritise clear communication and emotional support throughout your testing journey
Take Control of Your Lung Cancer Treatment Today
Don’t leave your treatment decisions to chance. The FISH NSCLC ALK1 ROS1 Test provides the genetic clarity needed for personalised, effective cancer care. With our special pricing of ZAR 5,350 and rapid 4-day results, you can move forward with confidence.
Ready to get started? Contact your oncologist about this test or reach out to our team for guidance. Every day matters in cancer treatment – take this important step toward personalised care today.
Note: This test requires a formalin-fixed paraffin-embedded tissue block with 10% tumor tissue and a completed Chromosome & FISH analysis Requisition Form (Form 17). Please consult with your healthcare provider.
